News

BioStat® Research
& Development Centre

2024 2023 2022 older
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
04
October
2018
Big Data Analyses - BioStat voice in an important case
04
October
2018

Big Data Analyses - BioStat voice in an important case

On behalf of the largest Polish pharmaceutical group, our BioStat team of experts has joined a project devoted to statistical analysis for comparison of mono- and polytherapy effectiveness in treating arterial hypertension. This is a unique project due to its scale – the data analysed are from over 100 thousand patients from the United Kingdom.

Due to the amount of variables observed, the team uses a „Big Data” method of analysis:
www.statystyka.az.pl/big-data

This is an innovative project at the level of, both, company and pharmaceutical sectors in Poland. It will provide a better understanding of the positive, as well as negative consequences of changing the therapy and  the practicality of implementing such enormous set of data for scientific research.

 

Copyright© 2023 Biostat
Cookies